Beijing Wandong Medical Technology Co.,Ltd. (SHA:600055)
China flag China · Delayed Price · Currency is CNY
10.23
-0.29 (-2.76%)
Sep 11, 2026, 3:00 PM CST

SHA:600055 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,2191,2151,4281,1611,0671,102
Other Revenue
159.67131.9396.2775.7354.2354.15
1,3781,3471,5241,2371,1211,156
Revenue Growth
-17.35%-11.63%23.26%10.30%-3.02%2.14%
Cost of Revenue
1,1211,011973.65719.49629.87633.98
Gross Profit
257.74335.88550.7517.18491.33522.2
Selling, General & Admin
415.37404.71286.52299.22241.1255.23
Research & Development
275.67263.19165.23157.56137.76111.48
Other Operating Expenses
30.7313.2914.83-24.93-18.02-25.88
Operating Expenses
765.41707.22483.81438.12366.41335.5
Operating Income
-507.67-371.3566.8979.06124.93186.69
Interest Expense
-1.17-1.27-1.65-1.25-1.47-1.51
Interest & Investment Income
58.8157.6678.7589.4283.1347.09
Currency Exchange Gain (Loss)
-32.55-12.274.720.5710.02-1.9
Other Non Operating Income (Expenses)
-21.62-20.98-5.23-1.64-17.79-23.01
EBT Excluding Unusual Items
-504.19-348.22143.49166.16198.82207.36
Gain (Loss) on Sale of Investments
-1.41-0.87-334.59-3.47-2.14
Gain (Loss) on Sale of Assets
-0.04-0.080.12-0.67-1.92-0.25
Asset Writedown
-0.03-0.03-0.02--2.3-
Legal Settlements
-----0.18-0.06
Other Unusual Items
52.7748.6926.2713.251.492.31
Pretax Income
-452.9-300.51166.86213.33192.44207.22
Income Tax Expense
-82.9-72.728.2222.5220.426.96
Earnings From Continuing Operations
-370-227.79158.64190.81172.04180.26
Minority Interest in Earnings
-0.83-0.07-1.29-2.273.332.93
Net Income
-370.83-227.86157.35188.54175.37183.19
Net Income to Common
-370.83-227.86157.35188.54175.37183.19
Net Income Growth
---16.54%7.51%-4.27%-16.98%
Shares Outstanding (Basic)
702703702701659536
Shares Outstanding (Diluted)
702703702701659536
Shares Change
-0.26%0.12%0.22%6.31%23.08%0.01%
EPS (Basic)
-0.53-0.320.220.270.270.34
EPS (Diluted)
-0.53-0.320.220.270.270.34
EPS Growth
---16.73%1.13%-22.22%-16.99%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-235.06-350.95179.64191.09171.3677.87
Free Cash Flow Per Share
-0.34-0.500.260.270.260.14
Dividend Per Share
--0.1300.1300.1200.100
Dividend Growth
--0%8.33%20.00%-23.08%
Gross Margin
18.70%24.93%36.13%41.82%43.82%45.17%
Operating Margin
-36.83%-27.57%4.39%6.39%11.14%16.15%
Profit Margin
-26.90%-16.92%10.32%15.25%15.64%15.85%
Free Cash Flow Margin
-17.05%-26.05%11.78%15.45%15.28%6.73%
EBITDA
-462.85-332.28101.5112.13156.21221.21
EBITDA Margin
-33.58%-24.67%6.66%9.07%13.93%19.13%
D&A For EBITDA
44.8139.0734.6133.0731.2834.52
EBIT
-507.67-371.3566.8979.06124.93186.69
EBIT Margin
-36.83%-27.57%4.39%6.39%11.14%16.15%
Effective Tax Rate
--4.92%10.56%10.60%13.01%
Revenue as Reported
1,3781,3471,5241,2371,1211,156
Advertising Expenses
-2.213.62.412.852.82